The generic drug maker Teva Pharmaceuticals agreed Monday, Aug. 21, 2023, to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results